Parc de Salut Mar

parcdesalutmar.cat

Total trials

179

Active

27

Phase 3

4

Total enrollment

66,374

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 9 of 9 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Calcifediol Oral1
Duloxetine1
Bevacizumab1
Ranibizumab Ophthalmic1
Inhaled Corticosteroids1
Fixed-Dose Combination of Inhaled Corticosteroids and Long- Acting Beta-agonist1
Other treatments1
Inhaler device1
Pain-Relief Medication1

Next readouts

  • 2025-10-31
  • 2025-12-31
  • 2026-07
  • 2026-07-31
  • 2027-06

Top conditions

  • Healthy Volunteers13
  • Healthy9
  • Psychological Trauma8
  • Colonic Diseases5
  • Heart Failure5
  • Down Syndrome4
  • Ankyloglossia3
  • Depression3

Frequently asked questions about Parc de Salut Mar

How many clinical trials does Parc de Salut Mar have on ClinicalTrials.gov?
Parc de Salut Mar is listed as the lead sponsor on 179 clinical trials in ClinicalTrials.gov, 27 of which are currently active (recruiting, enrolling, or ongoing).
How many of Parc de Salut Mar's trials are in Phase 3?
4 of Parc de Salut Mar's trials are in Phase 3, spread across 9 active drug programs.
What therapeutic areas does Parc de Salut Mar focus on?
Parc de Salut Mar's most-studied conditions on ClinicalTrials.gov are Healthy Volunteers, Healthy, Psychological Trauma, Colonic Diseases, Heart Failure.
When are Parc de Salut Mar's next clinical trial readouts?
Parc de Salut Mar has 5 upcoming primary-completion readouts tracked here; the soonest is “Asthma Research in Children and Adolescents”, expected around 2025-10-31.